Skip to main content
PYC THERAPEUTICS LIMITED logo

PYC THERAPEUTICS LIMITED — Investor Relations & Filings

Ticker · PYC ISIN · AU000000PYC7 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,297 across all filing types
Latest filing 2017-04-25 Interim / Quarterly Rep…
Country AU Australia
Listing ASX PYC

About PYC THERAPEUTICS LIMITED

https://pyctx.com/

PYC Therapeutics Limited is a clinical-stage company focused on developing precision medicines for patients with rare genetic diseases. The company utilizes a proprietary drug delivery platform that combines naturally derived cell-penetrating peptides with antisense oligonucleotides to create RNA-based therapeutics. This platform is designed to overcome the challenges of delivering large therapeutic molecules into target cells, particularly within the eye and central nervous system. PYC's primary pipeline includes VP-001, a candidate for Retinitis Pigmentosa type 11, and PYC-001, targeting Autosomal Dominant Optic Atrophy. Additionally, the company is advancing programs for Polycystic Kidney Disease. By leveraging its delivery technology, PYC aims to address the underlying genetic causes of diseases that currently lack effective treatment options.

Recent filings

Filing Released Lang Actions
Appendix 4C - quarterly 5 pages 52.4KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Appendix 4C Quarterly report for entities subject to Listing Rule 4.7B' and contains detailed consolidated cash flow statements for the quarter ended 31 March 2017. It includes operating, investing, and financing cash flows, payments to directors, financing facilities, estimated cash outflows for the next quarter, and compliance statements. The content is a comprehensive financial report for a quarter, not just an announcement or certification. The presence of actual financial data and analysis for a period shorter than a full fiscal year aligns with the definition of an Interim / Quarterly Report (IR). Q3 2017
2017-04-25 English
Board Renewal 3 pages 160.1KB
Board/Management Information Classification · 95% confidence The document is a news release announcing the appointment of new non-executive directors to the board of Phylogica Ltd. It details the backgrounds of the new directors and the retirement of an existing director. There is no financial data, no mention of a report or financial results, and no regulatory filing or certification. The content is focused on changes in the company's board of directors, which fits the category of Board/Management Information (MANG). The document length is about 7,100 characters, which is sufficient for a detailed announcement but does not contain financial statements or other report data. Therefore, the appropriate classification is MANG with high confidence.
2017-04-17 English
Initial Director's Interest Notice (two directors) 4 pages 831.5KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the initial interests of directors in securities, including registered and non-registered holdings, and interests in contracts. The content is focused on reporting personal shareholdings and interests of company directors. This matches the definition of 'Director's Dealing' filings, which report personal share transactions or interests by company directors and executives. The document length is 3929 characters, which is consistent with a notice rather than a full report. Therefore, the correct classification is DIRS (Director's Dealing).
2017-04-17 English
Final Director's Interest Notice 2 pages 553.2KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Z Final Director’s Interest Notice' and references ASX listing rule 3.19A.3 and section 205G of the Corporations Act. It details the cessation of a director and the director's interests in securities, with explicit mention of 'Final Director’s Interest Notice'. The content focuses on the director's personal share transactions and holdings, which aligns with insider trading or director dealings disclosures. The document length is short (2173 characters) and contains no financial statements or company performance data. Therefore, it fits the category of Director's Dealing (DIRS).
2017-04-17 English
Operational Update March Quarter 5 pages 244.7KB
Management Reports Classification · 95% confidence The document is titled 'Operational Update' and dated April 4, 2017. It provides a detailed progress report on the company's key focus areas, including technology development, oncology program progress, and external collaborations. The content includes scientific and developmental updates, preclinical study progress, and commercial collaboration status. There are no financial statements, earnings highlights, or regulatory certifications. The document is a comprehensive update on business operations and R&D progress rather than a formal financial report or regulatory filing. It is not an earnings release, annual or interim report, or audit report. It is also not a presentation or a voting result announcement. The nature of the document fits best with a Management Report (MDA), which typically includes management's detailed explanation of business trends, progress, and outlook. The length and detail support this classification with high confidence.
2017-04-03 English
New website released 1 page 20.3KB
Regulatory Filings Classification · 95% confidence The document is a short announcement about the launch of a refreshed company website. It contains no financial data, no regulatory filings, no meeting materials, no voting results, no management or board changes, no legal or capital updates, and no report attachments. The length is only 506 characters, indicating it is a brief announcement. It does not fit into any specific detailed report category. Therefore, it falls under the fallback category of Regulatory Filings (RNS) as a general announcement.
2017-04-02 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.